A significant advance in cancer research is occurring with the use of nanobodies to re-engage mutated p53. This essential malignant inhibitor protein is frequently lost in several kinds of cancer, resulting https://bookmarkprobe.com/story22228340/vhh-fragments-reactivate-p53-new-new-approach-for-malignant-treatment